STOCK TITAN

iSpecimen to Participate in Maxim’s 2022 Virtual Growth Conference on March 28-30, 2022

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

iSpecimen (Nasdaq: ISPC) has announced that CEO Christopher Ianelli will participate in the Maxim Group’s 2022 Virtual Growth Conference from March 28-30, 2022. The corporate presentation will be available on-demand starting March 28, 2022, at 9:00 a.m. ET for all registrants. iSpecimen connects scientists with healthcare providers through its online marketplace for biospecimens essential for medical research. For more details about the conference or one-on-one meetings, attendees can reach out to Maxim representatives or KCSA Strategic Communications.

Loading...
Loading translation...
Argus Session date unavailable
+8.22% session move Open Argus
Details

News Market Reaction – ISPC

The recorded move for ISPC in the trading session of this news was +8.22%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

LEXINGTON, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global, proprietary online marketplace connecting scientists with healthcare providers to search for biospecimens needed for medical research, today announced that Christopher Ianelli, MD, PhD, CEO and President of iSpecimen, will participate in Maxim Group’s 2022 Virtual Growth Conference to be held virtually on March 28-30, 2022.

Dr. Ianelli's corporate presentation will be available on-demand starting Monday, March 28, 2022, at 9:00 a.m. ET for all registrants of the virtual conference. To attend, please register here.

For more information about the Maxim conference, or to schedule a one-on-one meeting with iSpecimen’s management, please contact your appropriate Maxim representative directly, or send an email to KCSA Strategic Communications at iSpecimen@kcsa.com.

About iSpecimen
iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit www.ispecimen.com.

For further information, please contact:

Investor Contact
KCSA Strategic Communications
Allison Soss
iSpecimen@kcsa.com

Media Contact
KCSA Strategic Communications
Caitlin Kasunich / Raquel Cona
iSpecimen@kcsa.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the Maxim Group’s 2022 Virtual Growth Conference for iSpecimen?

The conference will be held virtually from March 28-30, 2022.

Who is the CEO of iSpecimen participating in the conference?

Christopher Ianelli, MD, PhD, is the CEO and President of iSpecimen.

What will be available on-demand at the conference?

iSpecimen's corporate presentation will be available on-demand starting March 28, 2022, at 9:00 a.m. ET.

How can I register for iSpecimen’s presentation at the conference?

You can register for the conference by visiting the Maxim Group website.

What does iSpecimen do?

iSpecimen connects scientists with healthcare providers for biospecimens needed for medical research.

Keep reading